neutral
4 days agoCorona Remedies IPO Highlights Share Allotment History and Promoter Lock-In Rules
According to the RHP, Corona Remedies’ equity structure has evolved through cash issuances, bonus allotments, gifts, and family partitions since 2009, with major bonus issues in 2010, 2011, and 2021 expanding its share capital significantly. The IPO includes an Offer for Sale worth ₹655.37 crore and a ₹5.85 crore employee reservation. The company also confirmed that promoter holdings exceeding minimum SEBI requirements will remain locked in for six months from the allotment date.
Tags:
- IPO
- Corona Remedies
Explore:Mutual Fund Screening
neutral
4 days agoCorona Remedies IPO Highlights Share Allotment History and Promoter Lock-In Rules
According to the RHP, Corona Remedies’ equity structure has evolved through cash issuances, bonus allotments, gifts, and family partitions since 2009, with major bonus issues in 2010, 2011, and 2021 expanding its share capital significantly. The IPO includes an Offer for Sale worth ₹655.37 crore and a ₹5.85 crore employee reservation. The company also confirmed that promoter holdings exceeding minimum SEBI requirements will remain locked in for six months from the allotment date.
Tags:
- IPO
- Corona Remedies
Explore:Mutual Fund Screening
1 min read
73 words
Corona Remedies’ RHP outlines extensive past share allotments, a ₹655 crore OFS, and mandatory six-month lock-in for excess promoter holdings under SEBI rules.
According to the RHP, Corona Remedies’ equity structure has evolved through cash issuances, bonus allotments, gifts, and family partitions since 2009, with major bonus issues in 2010, 2011, and 2021 expanding its share capital significantly. The IPO includes an Offer for Sale worth ₹655.37 crore and a ₹5.85 crore employee reservation. The company also confirmed that promoter holdings exceeding minimum SEBI requirements will remain locked in for six months from the allotment date.
According to the RHP, Corona Remedies’ equity structure has evolved through cash issuances, bonus allotments, gifts, and family partitions since 2009, with major bonus issues in 2010, 2011, and 2021 expanding its share capital significantly. The IPO includes an Offer for Sale worth ₹655.37 crore and a ₹5.85 crore employee reservation. The company also confirmed that promoter holdings exceeding minimum SEBI requirements will remain locked in for six months from the allotment date.
Tags:
- IPO
- Corona Remedies
- IPO
- Corona Remedies
- RHP
- SEBI
Dec 11, 2025 • 06:25